Skip to main content
OpenTrials

Clinical trial condition

Genital Diseases, Female

Explore clinical trials studying Genital Diseases, Female. Study availability and eligibility vary by location and protocol.

7,668 public trials 1,508 recruiting studies
Refine in advanced search Browse all conditions

Genital Diseases, Female trial results

Active, Not Recruiting

A Study of Avutometinib + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer in Japanese Patients

NCT06682572

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • Kurume University Hospital Kurume, Fukuoka, Japan
  • Mie University Hospital Tsu, Mie-ken, Japan
  • Tohoku University Hospital Sendai, Miyagi, Japan
View Trial Details
Active, Not Recruiting

Effect of Addition of Steroids on Duration of Analgesia

NCT04126824

Conditions
Adenomyosis, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • University of California, Los Angeles Westwood, Los Angeles, California, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
View Trial Details
Active, Not Recruiting

Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

NCT01844986

Conditions
Adnexal Diseases, Advanced Ovarian Cancer, BRCA Mutation, +24 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Providence Cancer Center Anchorage, Alaska, United States
  • St. Joseph's Hospital & Medical Center Phoenix, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 177 locations
View Trial Details
Active, Not Recruiting

Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line

NCT05201547

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +14 more
Locations
  • Canberra Hospital Garran, Australia
  • Calvary Mater Newcastle Waratah, Australia
  • Princess Margaret Cancer Centre Toronto, Canada
  • CHU d'Amiens - Hôpital Sud Amiens, France
View all 100 locations
View Trial Details
Active, Not Recruiting

Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.

NCT03983954

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenoma, +79 more
Locations
  • Shalby Hospital Ahmedabad, Gujarat, India
  • National Cancer Institute Jhajjar, Haryana, India
  • All India Institute of Medical Sciences New Delhi, India
  • PMCH (Pacific Medical College & Hospital) Udaipur, Rajasthan, India
View Trial Details

Related conditions